Neuralink's international trials are its versions of PRIME run outside the United States.
They are CAN-PRIME in Toronto, GB-PRIME in London and Newcastle, and UAE-PRIME in Abu Dhabi. Each needs approval from its own country's regulator, and the trial sites list shows which hospitals have reported implants.